Abiopharma

🔍 Young Seth Adam (Executive)

Company: High Roller Technologies, Inc. (ROLR)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Acquired 120,500 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 208,296.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reported transaction involved the Reporting Person's receipt of 120,500 restricted stock units ("RSUs"). The RSUs were granted pursuant to the High Roller Technologies, Inc. 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock upon vesting. Of the total RSUs reported, 70,000 RSUs shall vest in equal quarterly installments over a period of three years, and the remaining 50,500 RSUs are subject to vesting upon the achievement of certain performance conditions, as determined and certified by the board of directors of the Issuer, subject to the Reporting Person's continued service.
• F2: The total reported in Column 5 includes (i) the 120,500 newly awarded RSUs, (ii) 75,000 RSUs of which 0 have vested and (iii) 12,796 shares of common stock.